Neurocrine Biosciences (NBIX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neurocrine Biosciences (NBIX)

NBIX 145.00

+2.2%

Dec 19 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: software salesperson who wrote (1605)	6/23/2006 8:45:36 PM
From: zeta1961	Read Replies (1) of 1834

When did ya'll learn of the 20mg data being used for 15mg dosing? and why was this dose chosen?..If investors didn't find out 'til last month, that would qualify him/PFE for investor lawsuits?..Following from the sidelines..I can't help wondering whether Pfizer got wind of the FDA's long term sentiment..What do ya'll think is NBIX's best chance for survival?.. Does anyone know what's in the insomnia pipe?..Seroquel in low doses is being used by psychiatrists..I find it very concerning that our medical establishment dispenses a drug as complex as these new anti-psychotics in this indication..I'm probably stating the obvious, again :-(

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next